Skip to main content

Cancer Biology Experts and Information for Media

The Cancer Biology Program at St. Jude Children’s Research Hospital is a transdisciplinary research program. Driven by research in fundamental biological science, the program leads intergrated efforts to understand cancer at the most basic cellular and biochemical levels.

The following cancer biology experts are available to offer credible information, hands-on expertise and insight in cancer biology, including developmental neurobiology and oncogenesis.

To schedule interviews or speak with one of our experts, email media@stjude.org or contact one of our media relations staff.

Contact Media Relations

Cancer Biology Experts

  • Michael A. Dyer, PhD

    Michael Dyer, PhD, is the Developmental Neurobiology chair and the Developmental Biology and Solid Tumor Program co-leader at St. Jude Children’s Research Hospital and is a Howard Hughes Medical Institute investigator. His lab studies the basic science of how neural progenitor cells coordinate their numbers and identity as they mature into different cell types and tissues in the brain and central nervous system. Recently, Dyer has been able to extend the findings of his research to apply to other developing tissues relevant to pediatric solid tumors, including bone and muscle. Dyer also collaborates on new imaging techniques to use light microscopy that tracks the location of certain genes in developing neuronal cells. He is available to discuss his research and the Childhood Solid Tumor Network, the world's largest and most comprehensive collection of scientific resources for researchers studying pediatric solid tumors and related biology.

  • Martine F. Roussel, PhD

    Martine Roussel, PhD, is the Cancer Biology Program co-leader and Molecular Oncogenesis chair at St. Jude Children’s Research Hospital. Roussel has made landmark discoveries in molecular oncology, cell cycle control and translational development of treatment strategies for pediatric medulloblastoma, the most common malignant pediatric brain tumor. She identified several of the earliest recognized retroviral oncogenes and worked out their physiological functions in signal transduction, regulation of gene expression, cell cycle dynamics and organismal development. Roussel is an internationally recognized expert and member of the National Academy of Sciences who can provide considerable insight on the regulation of the G1 phase of the cell cycle and proliferation as it relates to pediatric cancers. She can also provide information on the multidiciplary approach involved with cancer biology.

  • J. Paul Taylor, MD, PhD

    J. Paul Taylor, MD, PhD, is the Cell and Molecular Biology chair at St. Jude Children’s Research Hospital and a Howard Hughes Medical Institute investigator. His research aims to reduce morbidity and mortality from neurological diseases, including amyotrophic lateral sclerosis (ALS), Taylor’s research leverages the fruit fly (Drosophila melanogaster) model for genetic studies. He has identified genes responsible for ALS and learned how mutations in these genes disrupt the way cells process RNA. These findings open new avenues for researchers seeking treatments for those living with ALS, a disorder that kills most patients within five years of diagnosis. Using small molecule screens and fruit fly models, his team also identified a new druggable target for the treatment of another motor neuron disease, spinal bulbar muscular atrophy. Taylor can provide information on advances in cell and molecular biology.

Close